Unlock stock picks and a broker-level newsfeed that powers Wall Street.
IOB - Delayed Quote EUR

Bayer Aktiengesellschaft (0P6S.IL)

Compare
20.09
-1.27
(-5.94%)
At close: April 4 at 7:03:49 PM GMT+1
Loading Chart for 0P6S.IL
  • Previous Close 21.36
  • Open 21.06
  • Bid 19.99 x --
  • Ask 20.30 x --
  • Day's Range 19.65 - 21.42
  • 52 Week Range 18.41 - 31.03
  • Volume 1,648,605
  • Avg. Volume 888,311
  • Market Cap (intraday) 19.777B
  • Beta (5Y Monthly) 0.97
  • PE Ratio (TTM) --
  • EPS (TTM) -2.94
  • Earnings Date May 13, 2025
  • Forward Dividend & Yield 0.11 (0.39%)
  • Ex-Dividend Date Apr 29, 2024
  • 1y Target Est --

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

www.bayer.com

96,931

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0P6S.IL

View More

Performance Overview: 0P6S.IL

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

0P6S.IL
4.90%
DAX P (^GDAXI)
3.68%

1-Year Return

0P6S.IL
29.38%
DAX P (^GDAXI)
12.16%

3-Year Return

0P6S.IL
66.56%
DAX P (^GDAXI)
42.18%

5-Year Return

0P6S.IL
49.27%
DAX P (^GDAXI)
116.69%

Compare To: 0P6S.IL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0P6S.IL

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    19.74B

  • Enterprise Value

    52.35B

  • Trailing P/E

    --

  • Forward P/E

    8.20

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.42

  • Price/Book (mrq)

    0.62

  • Enterprise Value/Revenue

    1.12

  • Enterprise Value/EBITDA

    5.94

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.17%

  • Return on Assets (ttm)

    4.04%

  • Return on Equity (ttm)

    -8.17%

  • Revenue (ttm)

    47.64B

  • Net Income Avi to Common (ttm)

    -2.94B

  • Diluted EPS (ttm)

    -2.94

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.59B

  • Total Debt/Equity (mrq)

    136.06%

  • Levered Free Cash Flow (ttm)

    1.52B

Research Analysis: 0P6S.IL

View More

Company Insights: 0P6S.IL

Research Reports: 0P6S.IL

View More

People Also Watch